Pulse Biosciences Inc

+0.17 (+0.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)543.46M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.86 Million
Adjusted EPS-$0.50
See more estimates
10-Day MA$19.63
50-Day MA$21.38
200-Day MA$21.37
See more pivots

Pulse Biosciences Inc Stock, NASDAQ:PLSE

3957 Point Eden Way, 3957 Point Eden Way, Hayward, California 94545
United States of America
Phone: +1.510.906.4600
Number of Employees: 95


Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.